Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02574793 : Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- •newly diagnosed GH-releasing pituitary adenoma

- •newly diagnosed Cushing Syndrome

Exclusion Criteria:

- •history of diabetes mellitus and being treated with drugs

- •being treated with drugs which affect glucose metabolism in the lately 3 months

- •with other hormones affecting glucose metabolism secreted abnormally by pituitary

- •serious comorbidity like malignant tumour, severe hepatosis or nephropathy, serious
hypertension(blood pressure> 180/110mmhg)

- •pregnant or breastfeeding women

- •patients allergic to patches or metal
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02574793      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740